Page last updated: 2024-11-02

pantoprazole and Retinoblastoma

pantoprazole has been researched along with Retinoblastoma in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Retinoblastoma: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pascual-Pasto, G1
Olaciregui, NG1
Opezzo, JAW1
Castillo-Ecija, H1
Cuadrado-Vilanova, M1
Paco, S1
Rivero, EM1
Vila-Ubach, M1
Restrepo-Perdomo, CA1
Torrebadell, M1
Suñol, M1
Schaiquevich, P1
Mora, J1
Bramuglia, GF1
Chantada, GL1
Carcaboso, AM1

Other Studies

1 other study available for pantoprazole and Retinoblastoma

ArticleYear
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, Oct-28, Volume: 264

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Mem

2017